GlaxoSmithKline LLC has recalled 463 cartons of Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension, a medication used to treat HIV. The recall was initiated because the outer cartons were printed with an incorrect expiration date of May 2026, whereas the actual expiration date of the medication is April 2025. While the date on the individual tablet bottle inside is correct, the error on the outer carton could lead patients to use the medicine after it has expired.
Using medication past its true expiration date may result in the drug being less effective at treating the underlying condition. If a patient continues to use this medication between May 2025 and May 2026 based on the incorrect carton label, they would be taking expired medicine.
You have 2 options:
Each carton contains one bottle of 60 tablets, one 30-mL dosing cup and one 10-mL oral dosing syringe.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.